{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:46:53Z","timestamp":1776329213074,"version":"3.50.1"},"reference-count":32,"publisher":"Royal College of Psychiatrists","issue":"4","license":[{"start":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T00:00:00Z","timestamp":1514851200000},"content-version":"unspecified","delay-in-days":10503,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Psychiatry"],"published-print":{"date-parts":[[1989,4]]},"abstract":"<jats:p>Fifty-one outpatients presenting with generalised anxiety disorder were included in a double-blind trial, and treated with either buspirone (a new non-benzodiazepine antianxiety drug) or diazepam over 6 or 12 weeks, after which they were abruptly withdrawn and continued on placebo to 14 weeks. Ratings of anxiety and other symptoms were administered fortnightly and additional withdrawal symptoms noted. Forty patients completed the study; 8 of the 11 drop-outs were taking buspirone. Both drugs reduced anxiety, diazepam more rapidly, but with greater withdrawal symptoms, particularly after 6 weeks. Regular treatment with diazepam for 6 weeks leads to a significant risk of pharmacological dependence that is not present with buspirone.<\/jats:p>","DOI":"10.1192\/bjp.154.4.529","type":"journal-article","created":{"date-parts":[[2008,8,13]],"date-time":"2008-08-13T00:01:46Z","timestamp":1218585706000},"page":"529-534","source":"Crossref","is-referenced-by-count":62,"title":["Comparative Assessment of Efficacy and Withdrawal Symptoms After 6 and 12 Weeks' Treatment with Diazepam or Buspirone"],"prefix":"10.1192","volume":"154","author":[{"given":"Siobhan M.","family":"Murphy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Owen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Tyrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"170","published-online":{"date-parts":[[2018,1,2]]},"reference":[{"key":"S0007125000174859_ref32","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1980.01780140103012"},{"key":"S0007125000174859_ref24","doi-asserted-by":"publisher","DOI":"10.1159\/000284132"},{"key":"S0007125000174859_ref11","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.4.382"},{"key":"S0007125000174859_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(86)90329-3"},{"key":"S0007125000174859_ref29","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.47.9.970"},{"key":"S0007125000174859_ref18","first-page":"81","article-title":"Buspirone and diazepam in anxiety: a controlled study","volume":"43","author":"Rickels","year":"1982","journal-title":"Journal of Clinical Psychiatry"},{"key":"S0007125000174859_ref6","first-page":"103","article-title":"A double-blind comparison of buspirone and diazepam in outpatients with generalised anxiety disorder","volume":"43","author":"Feighner","year":"1982","journal-title":"Journal of Clinical Psychiatry"},{"key":"S0007125000174859_ref4","first-page":"409","article-title":"Low sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study","volume":"47","author":"Cohn","year":"1986","journal-title":"Journal of Clinical Psychology"},{"key":"S0007125000174859_ref13","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(85)90194-5"},{"key":"S0007125000174859_ref30","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.151.6.719"},{"key":"S0007125000174859_ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)92861-0"},{"key":"S0007125000174859_ref22","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700009314"},{"key":"S0007125000174859_ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.290.6477.1246"},{"key":"S0007125000174859_ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.283.6292.643"},{"key":"S0007125000174859_ref1","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1980"},{"key":"S0007125000174859_ref27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)92355-3"},{"key":"S0007125000174859_ref25","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM198603133141121","article-title":"Resistance to the antianxiety effects of buspirone in patients with a history of benzodiazepine use","volume":"314","author":"Schweizer","year":"1986","journal-title":"New England Journal of Medicine"},{"key":"S0007125000174859_ref19","first-page":"51","volume-title":"138 Annual Meeting of the American Psychiatric Association, Dallas, May 18\u201324.","author":"Rickels","year":"1985"},{"key":"S0007125000174859_ref21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1976.03270200012009"},{"key":"S0007125000174859_ref10","first-page":"62","article-title":"Psychological effects of buspirone","volume":"43","author":"Lader","year":"1982","journal-title":"Journal of Clinical Psychiatry"},{"key":"S0007125000174859_ref31","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(86)90343-2"},{"key":"S0007125000174859_ref5","volume-title":"The Analysis of Binary Data.","author":"Cox","year":"1970"},{"key":"S0007125000174859_ref23","doi-asserted-by":"publisher","DOI":"10.1192\/pb.12.3.107"},{"key":"S0007125000174859_ref17","doi-asserted-by":"publisher","DOI":"10.1159\/000284133"},{"key":"S0007125000174859_ref7","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1176\/ajp.141.7.848","article-title":"Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment","volume":"141","author":"Fontaine","year":"1984","journal-title":"American Journal of Psychiatry"},{"key":"S0007125000174859_ref9","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1985.tb03430.x"},{"key":"S0007125000174859_ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198610023151403"},{"key":"S0007125000174859_ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1978.tb02357.x"},{"key":"S0007125000174859_ref28","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(84)90048-7"},{"key":"S0007125000174859_ref20","volume-title":"Psychopharmacoiogy of Anxiety","author":"Rickels","year":"1989"},{"key":"S0007125000174859_ref15","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1978.01770320089008"},{"key":"S0007125000174859_ref12","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198706000-00005"}],"container-title":["British Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007125000174859","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T20:49:03Z","timestamp":1558298943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007125000174859\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1989,4]]}},"alternative-id":["S0007125000174859"],"URL":"https:\/\/doi.org\/10.1192\/bjp.154.4.529","relation":{},"ISSN":["0007-1250","1472-1465"],"issn-type":[{"value":"0007-1250","type":"print"},{"value":"1472-1465","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,4]]}}}